Boston Scientific's decision to stop selling coaptite boosts Axonics stock as investors see it as a move to ease ...

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Boston Scientific (BSX – Research ...

The Boston Scientific Mobile Learning Lab visited the St. Peter’s Hospital campus on Thursday, September 19, offering clinical staff an opportunity to take part in high-tech, interactive ...

Boston Scientific (NYSE: BSX) has more than doubled in value since early January 2021 – jumping from levels of $36 then to around $82 now – vs. an increase of about 45% for the S&P 500 over ...

MARLBOROUGH, Mass., Sept. 17, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Silk Road Medical, Inc. (Nasdaq: SILK), a medical ...

Boston Scientific Corp. (BSX) announced Friday that it has received Pharmaceuticals and Medical Device Agency approval in Japan for ...

The stock's fall snapped a two-day winning streak.

On Monday, Boston Scientific Corporation (BSX) stock saw a decline, ending the day at $84.41 which represents a decrease of $-0.13 or -0.15% from the prior close of $84.54. The stock opened at $84.38 ...

On Wednesday, Boston Scientific Corporation (BSX) stock saw a modest uptick, ending the day at $84.49 which represents a slight increase of $0.35 or 0.42% from the prior close of $84.14. The stock ...

EVP Joseph Michael Fitzgerald sold 132,527 shares of Boston Scientific stock in a transaction dated Monday, October 7th. The ...